Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic’s Anila Patel and Head of Health Technology Sector, Mary Virzi, to chat about what MedTech moves we’ve seen so far and what we can expect as 2024 kicks into gear.

Podcast Tags: healthcare, medtech, product launch, medical device, health tech, healthcare technology 

Source Links: 

• The biggest stories from the 2024 J.P. Morgan Healthcare Conference 
• 5 medtech trends to watch in 2024 
• MEDTECH AND DIAGNOSTICS MARKET: 2023 TRENDS AND 2024 OUTLOOK 
• Medtronic aims to leverage medical device data for AI-enabled care 
• 4 heart device trends shaping the medtech sector in 2024 
• J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year 
• Boston Scientific nets Farapulse approval, pushes back US TAVR launch 
• J&J\’s Biosense Webster puts forward pulsed field ablation data showing no afib after one year 
• Medtronic snags first pulsed field ablation approval in US 
• Spotlight – J&J takes on Medtronic and Boston in pulsed field ablation 
• Increasing diabetes awareness boosts the diabetes care devices market 

Panel – Mary Virzi, Anila Patel, Jen Burke 

Research & Production – Adrea Cope, Everly Petruzzelli 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.